Charité Campus Mitte, Med.Klinik, Rheumatologie und Klinische Immunologie

Berlin 10117

0 studies enrolling now · 2 studies all time

What they study most

Giant Cell Arteritis, Lupus Nephritis

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritis — Running, not enrolling
• An Efficacy and Safety Study of Tocilizumab (RoActemra/Actemra) in Participants With Giant Cell Arteritis (GCA) — Completed